Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹103Cr
Rev Gr TTM
Revenue Growth TTM
-11.26%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

SMLT
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -45.1 | -38.8 | -23.6 | -18.6 | -12.6 | -50.4 | -41.0 | -41.6 | -31.9 | 13.8 | -20.6 | 8.5 |
| 73 | 74 | 70 | 73 | 68 | 39 | 44 | 42 | 47 | 44 | 35 | 46 |
Operating Profit Operating ProfitCr |
| 9.7 | 9.2 | 9.3 | 3.3 | 3.7 | 4.0 | 4.2 | 4.7 | 2.8 | 3.8 | 4.5 | 4.4 |
Other Income Other IncomeCr | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 8 | 7 | 7 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 2 |
| 2 | 2 | 2 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -28.5 | -37.6 | -29.8 | -77.1 | -70.1 | -73.8 | -84.9 | -29.5 | -61.3 | -24.3 | -8.4 | 6.6 |
| 7.2 | 6.5 | 7.1 | 2.3 | 2.5 | 3.5 | 1.8 | 2.8 | 1.4 | 2.3 | 2.1 | 2.7 |
| 4.2 | 3.9 | 4.0 | 1.3 | 1.3 | 1.0 | 0.6 | 0.9 | 0.5 | 0.8 | 0.6 | 0.9 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -15.3 | 19.1 | 12.5 | 10.5 | 13.2 | 3.5 | 106.3 | -10.7 | -25.3 | -41.5 | 0.0 |
| 144 | 120 | 144 | 161 | 177 | 203 | 206 | 419 | 368 | 285 | 171 | 171 |
Operating Profit Operating ProfitCr |
| 4.9 | 6.5 | 5.7 | 6.0 | 6.4 | 5.3 | 7.2 | 8.3 | 9.8 | 6.5 | 3.9 | 3.8 |
Other Income Other IncomeCr | 1 | 1 | 2 | 2 | 2 | 1 | 0 | 4 | 3 | 2 | 3 | 2 |
Interest Expense Interest ExpenseCr | 3 | 3 | 3 | 3 | 4 | 4 | 3 | 4 | 1 | 1 | 1 | 0 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 |
| 4 | 5 | 6 | 7 | 8 | 6 | 11 | 36 | 40 | 19 | 6 | 6 |
| 1 | 2 | 2 | 2 | 2 | 2 | 3 | 8 | 10 | 5 | 2 | 2 |
|
| | 25.9 | 10.6 | 20.4 | 21.2 | -19.8 | 72.9 | 243.8 | 8.3 | -53.5 | -70.2 | -8.0 |
| 1.9 | 2.8 | 2.6 | 2.8 | 3.0 | 2.2 | 3.6 | 6.0 | 7.3 | 4.5 | 2.3 | 2.1 |
| 2.3 | 3.0 | 2.9 | 3.5 | 4.2 | 3.4 | 5.8 | 20.1 | 21.7 | 10.1 | 3.0 | 2.8 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Dec 2025 |
|---|
Equity Capital Equity CapitalCr | 12 | 12 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| 8 | 12 | 19 | 23 | 29 | 32 | 39 | 64 | 91 | 102 | 107 | 109 |
Current Liabilities Current LiabilitiesCr | 25 | 24 | 29 | 26 | 38 | 28 | 33 | 35 | 4 | 3 | 3 | 2 |
Non Current Liabilities Non Current LiabilitiesCr | 1 | 1 | 1 | 3 | 3 | 2 | 5 | 3 | 1 | 1 | 2 | 2 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 38 | 40 | 52 | 54 | 68 | 58 | 76 | 102 | 96 | 104 | 104 | 93 |
Non Current Assets Non Current AssetsCr | 8 | 9 | 11 | 11 | 16 | 18 | 16 | 14 | 14 | 16 | 20 | 33 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | 5 | 4 | 0 | 1 | 17 | -1 | 16 | 35 | 27 | 0 |
Investing Cash Flow Investing Cash FlowCr | 0 | -1 | -2 | -2 | -6 | -3 | -1 | 3 | -2 | -3 | -6 |
Financing Cash Flow Financing Cash FlowCr | 0 | -3 | 6 | -6 | 7 | -17 | 4 | -15 | -26 | -3 | 0 |
|
Free Cash Flow Free Cash FlowCr | 0 | 3 | 2 | -2 | -5 | 14 | -2 | 19 | 32 | 22 | -7 |
| 0.0 | 135.5 | 103.9 | 0.8 | 19.7 | 370.8 | -7.0 | 59.8 | 117.5 | 193.9 | -4.7 |
CFO To EBITDA CFO To EBITDA% | 0.0 | 58.7 | 47.6 | 0.3 | 9.4 | 152.0 | -3.5 | 43.4 | 87.2 | 135.0 | -2.8 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 48 | 56 | 39 | 19 | 41 | 127 | 224 | 304 | 164 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 12.1 | 11.8 | 6.8 | 4.2 | 5.1 | 4.6 | 7.5 | 22.0 | 39.8 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.3 | 0.3 | 0.2 | 0.1 | 0.2 | 0.3 | 0.6 | 1.0 | 0.9 |
Price To Book Price To Book | 0.0 | 0.0 | 1.5 | 1.5 | 0.9 | 0.4 | 0.8 | 1.6 | 2.1 | 2.6 | 1.4 |
| 3.1 | 2.6 | 7.7 | 7.8 | 5.9 | 3.7 | 4.3 | 3.7 | 5.2 | 13.5 | 19.3 |
Profitability Ratios Profitability Ratios |
| 10.4 | 14.2 | 15.4 | 14.4 | 15.1 | 15.5 | 18.8 | 17.0 | 17.7 | 15.2 | 17.2 |
| 4.9 | 6.5 | 5.7 | 6.0 | 6.4 | 5.3 | 7.2 | 8.3 | 9.8 | 6.5 | 3.9 |
| 1.9 | 2.8 | 2.6 | 2.8 | 3.0 | 2.2 | 3.6 | 6.0 | 7.3 | 4.5 | 2.3 |
| 15.3 | 17.4 | 15.6 | 16.8 | 15.2 | 14.4 | 16.7 | 39.7 | 39.6 | 17.0 | 5.8 |
| 13.9 | 14.9 | 12.1 | 13.0 | 13.6 | 10.0 | 15.1 | 35.3 | 28.4 | 11.9 | 3.4 |
| 6.1 | 7.3 | 6.3 | 7.3 | 6.9 | 6.1 | 8.8 | 23.7 | 27.1 | 11.5 | 3.3 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Sarthak Metals Limited (SML), part of the ₹490+ crore Desraj Bansal Group (DB Group), is a leading Indian manufacturer and exporter of **metallurgical consumables**, with an evolving footprint in **welding consumables** and **biotechnology**. Headquartered in **Bhilai, Chhattisgarh**, the company leverages its strategic location near India’s steel heartland to serve top-tier domestic and international clients.
Founded in 1995, SML has transitioned from an industrial gases supplier to a diversified industrial solutions provider, driven by innovation, backward integration, and strategic diversification. Listed on the **BSE SME platform in 2017** and subsequently migrated to **BSE/NSE mainboards in November 2021**, SML is positioning itself for long-term sustainable growth across multiple high-potential sectors.
---
### **Strategic Pillars (Core Business Model)**
SML operates on **three strategic pillars**:
1. **Cored Wires & Aluminium Flipping Coils** – Established metallurgical solutions.
2. **Welding Consumables (Flux-Cored Wires)** – High-growth industrial expansion.
3. **Biotechnology (SSF-based Bio-Enzymes & Alternative Energy)** – Future-focused diversification.
This multi-engine growth strategy reduces reliance on the cyclical steel industry and enhances long-term resilience, profitability, and shareholder value.
---
## **Business Segments**
### **1. Core Business: Metallurgical Consumables**
#### **Cored Wires**
- **Annual Capacity**: 10,000 TPA across **four in-house developed production lines**.
- **Products**: Calcium Silicide, Ferro Titanium, Magnesium Ferrosilicon, and more. Used for **deoxidation, desulphurisation, grain refinement, and alloying** in steel and stainless steel production.
- **Advantages**: Replaces traditional lump addition with **homogeneous mixing**, reduced waste, and improved steel consistency.
- **Market Position**: One of India’s **leading manufacturers**, supplying **top 5 Indian steel companies** including Tata Steel, JSW, SAIL.
- **Customer Retention**: ~85% of business comes from **repeat customers**; over **125 clients**, with 45+ having 10+ year relationships.
- **Capacity Utilization**: Varies due to market cycles. FY24 output was **7,196 TPA** (down from 9,925 TPA in FY22), with recovery underway.
- **Certification & QC**: ISO 9001-2008 certified; **on-site atomic absorption spectrophotometer** ensures precision quality control.
#### **Aluminium Flipping Coils**
- **Annual Capacity**: 15,000 TPA (expanded in FY23 via addition of a third furnace).
- **Application**: Used in steel deoxidation, nitride formation, and strengthening low-carbon steels; superior alternative to ingots with better **precision, economy, and ease of use**.
- **Output Trends**: Production dropped from **6,705 TPA in FY22** to **4,505 TPA in FY24**, due to **margin pressures, rising scrap prices**, and **import competition**.
- **Strategic Move**: The company has **intentionally scaled down** operations in this segment to avoid unprofitable price wars and protect margins. A **final decision on the future** of this business was expected by mid-2025.
- **Export Focus**: Exploring export opportunities to diversify this product line.
---
### **2. Diversification: Welding Consumables (Flux-Cored Wires)**
A key strategic pivot, targeting **import substitution** and **industrial welding growth**.
#### **Market Opportunity**
- India imports **~90% of flux-cored arc welding (FCAW) consumables**, primarily from **China**.
- Domestic market valued at **₹3,000 crore**, largely unorganized.
- Strong demand from **infrastructure, construction, railways, shipbuilding, and energy**.
- Government’s **Atma Nirbhar Bharat** and **China+1** strategies create a favorable environment.
#### **SML’s Capabilities**
- **Production Capacity**: Expanded from **1,200 TPA in FY24** to **3,600 TPA in FY25**, supported by **3 dedicated production lines**.
- **Products**: 7 grades across **carbon steel, stainless steel, and hardfacing** categories, all **BIS, IBR, and IRS certified**.
- **RDSO Approval** (Apr 2025): A major milestone enabling supply to **Indian Railways** and engineering contractors.
- **Volume & Revenue Growth**:
- **Q2 FY26 Revenue**: ₹3.7 crore (up from ₹1.5 crore YoY).
- **Q1 FY26 Revenue**: ₹2.7 crore; **Q4 FY25: ₹2.4 crore**.
- **Volumes**: 338 tonnes in Q2 FY26 (**+168% YoY**); monthly sales rose from **60 tonnes (Feb 2025)** to **>100 tonnes (Nov 2025)**.
- **FY25 Full-Year Revenue**: ₹7.20 crore (from a new business line).
- **Target**: **₹25 crore annual revenue** from FCAW within **two years**.
- **Technology Edge**: Precise chemical formulations, high deposition rates, and weld quality give **attractive margins (~20% gross margin)**.
#### **Go-to-Market Strategy**
- Distribution network: **>10 dealers** across **5+ states**, with repeat orders indicating strong market acceptance.
- **Product Trials**: Successful trials on **7 new FCAW grades**, including hardfacing and stainless variants.
- **End-Use Applications**: Structural welding, boiler fabrication, wear-resistant surfacing, railways, oil & gas.
---
### **3. Emerging Venture: Biotechnology**
A transformative diversification into **industrial biotechnology**, leveraging fermentation for **bioethanol, biogas, and health & nutrition**.
#### **Strategic Drivers**
- India’s **bioeconomy target**: $300 billion by 2030 (from $92 billion in 2022).
- Government push for **2G ethanol, fuel blending, and green energy**.
- Address **low market penetration** in industrial enzymes and **export-ready** health-nutrition products.
#### **Facility & Partnerships**
- **Pilot R&D Plant**: Operational in **Nagpur, Maharashtra**, with **14 kg batch capacity** using **Solid State Fermentation (SSF)**.
- **First Batch**: Successfully produced in **May 2025**.
- **Key Partnerships**:
- **CSIR (Council of Scientific & Industrial Research)**: Exclusive access to **microbial cultures** (cellulase, betaglucosidase).
- **LIT University & Hislop College**: Technology transfer and R&D collaboration.
- **Investment**: ~₹50 lakh in pilot phase; **₹10 crore initial Capex**, with **planned investment of ₹100 crore** over 3–5 years.
#### **Products & Applications**
- **Industrial Enzymes**: For **cellulose degradation** in **2G ethanol and biogas production** (targeting distilleries like Reliance, Adani).
- **Wastewater Treatment, Detergents, Textiles**.
- **Health & Nutrition**: Protein isolates from **chana (chickpea)**, prebiotics, probiotics, dietary supplements – export-oriented.
- **Proprietary Tech**: Fermentation cycle reduced from **6 to 4 days**, targeting 3 days.
#### **Commercial Outlook**
- **Revenue Generation**: Expected to begin in **H2 FY25**, scaling rapidly post-standardization.
- **Long-Term Goal**: **100-tonne fermentation capacity**, with **CDMO (contract manufacturing)** potential.
- **Margin Potential**: Biotech could deliver **~30% EBITDA margins** vs. 15–20% in metals.
---
### **Manufacturing & Infrastructure**
- **Location**: Bhilai, Chhattisgarh – heart of India’s steel industry.
- **Facilities**: Three state-of-the-art plants on **~450,000 sq. ft.**, with **planned land for expansion**.
- **Production Lines**:
- **Cored Wires**: 4 lines (10,000 TPA)
- **Aluminium Flipping Coils**: 2 in-house lines (15,000 TPA)
- **Flux-Cored Wires**: 3 lines (3,600 TPA)
- **Backward Integration**: In-house production of **aluminium wire rods** (from 2018).
- **In-House Engineering**: Designs and builds own machinery for **cost control, customization, and faster expansion**.
- **Warehousing & Inventory**:
- **Cored Wires**: 1,500 sq. m., **2,000+ tonne buffer (3 months)**.
- **Aluminium Flipping Coils**: 2,800 sq. m., **4,000+ tonne buffer (4 months)**.
- **Laboratory**: Fully functional chemical lab with **AAS spectrophotometer** for end-to-end quality assurance.
---
### **Strategic Growth Initiatives**
1. **Export Expansion**
- Exports to **15+ countries** (Brazil, Turkey, South Africa, Australia).
- Aiming for **>25% export contribution** in 3–5 years.
2. **Foundry & Fabrication Expansion**
- Entering **SG Iron casting, automotive, and defence segments**.
- Custom formulation support to **metallurgists and plant engineers**.
3. **Capex & Expansion Plans**
- **Flux Cored Wires**: Plans to add **3 more lines (₹3 crore Capex)**, scalable to **9+ lines**.
- **Biotech**: Phased Capex of **₹100 crore**, starting with **GMP-like facility for enzymes and proteins**.
4. **Innovation & R&D**
- **5-member R&D team** focused on product development and process optimization.
- Over **7 new FCAW variants** in pipeline; **5–8 biotech SKUs** under development.
---
### **Financial Position & Strategy**
- **Balance Sheet**: **Debt-free**, with **healthy cash reserves** and **strong cash accruals**.
- **Turnaround in Core Business**: FY25 cored wire revenue grew **26% YoY to ₹36.5 crore** (volumes +16%).
- **Strategic Earnings Pivot**:
- **Aluminium flipping coil** revenue declined to **₹6.4 crore (Q4 FY25)** due to conscious exit from low-margin segments.
- Focus shifted to **higher-margin, value-added products** and **non-steel sectors**.
- **Future Earnings Mix**:
- **Cored Wires**: Stable core.
- **Flux-Cored Wires**: Target **₹25 crore/year**.
- **Biotechnology**: Potential for **₹40–50 crore/year**, with **higher valuation multiples**.
---
### **Management & Group Ecosystem**
- **Parent Group**: Desraj Bansal Group – 50+ years in **metallurgy and energy**.
- **Key Entities**:
- **Bansal Brothers**: Leading producer of **Ferro Titanium** (70% market share), key supplier to SML.
- **Sarthak Energy**: Energy vertical.
- **Synergy**: Access to **cost-competitive noble ferroalloys** provides SML with a **strategic pricing and supply advantage**.